Document de presse | 2008.07.07
Researchers from the Institut Pasteur in Paris and the Institut Pasteur in Lille have analyzed the consequences of intensive vaccination of young children against whooping cough on the bacterium agent of the disease. Their observations highlight the importance of continuing bacterial evolution in order to adapt vaccine strategies. Press release Paris, july 8, 2008 ...
Document de presse | 2023.12.14
International research consortium receives highly endowed Horizon Europe funding for the development of vaccines against Marburg viruses.The multidisciplinary European consortium MARVAX will receive 7.4 million euros over the next four years for the research and development of vaccines against Marburg viruses. Researchers from France, Spain and Germany will develop novel vaccine candidates, which...
News | 2017.10.06
Scientific, medical, paramedical societies, medical unions and the Institut Pasteur, all signatories below, support the policy for the prevention of infectious diseases implemented by the French Government and the Minister of Health.Vaccines are one of the major achievements of medicine, this is why the companies which sign this text, including the Institut Pasteur, support the French Government'...
News | 2015.05.21
The Institut Pasteur and the Institut Pasteur International network are releasing EBOV sequences to support the public health response as well as the development and evaluation of EVD vaccines, therapeutics, and diagnostics. Please feel free to download, use, and analyze this data.
Article | 2017.01.04
Up-to-date DT Polio vaccination is recommended with boosters at 25, 45, 65.For some classes you may require additional vaccinations prior to attendance. Please check the course description on the website.Students with a chronic medical condition or pregnant women are requested to seek advice from their family physician about any possible risks associated with attending classes...
News | 2016.10.10
La nouvelle diffusion du MOOC vaccinologie de l’Institut Pasteur est programmée le 5 décembre 2016. Les inscriptions ont débuté !L’Institut Pasteur est un acteur historique dans le domaine des vaccins, aujourd’hui considérés comme les principaux outils préventifs de la médecine humaine au regard de leur efficacité. Depuis la mise au point novatrice du vaccin contre la rage par...
Report | 2024.05.03
On April 26, 2024, the World Health Organization held a high-level meeting at the Institut Pasteur to highlight the importance of tackling meningitis, a disease that comes in multiple, often severe forms, some of which can kill in the space of hours. It is crucial that we improve our knowledge of meningitis. What are the symptoms, and how can it be prevented? Vaccination is the solution, both to...
Vidéo | 2025.03.10
Whooping cough is a respiratory infection that can be very serious for infants and frail people.It causes a persistent cough, difficulty in breathing and can last for several weeks.The good news is that prevention is possible!Vaccination remains the most effective means of protecting babies and adults.Antibiotics can limit contagion if administered promptly.Wearing a mask helps reduce...
Article | 2019.04.24
A new 4-year research group (G4) is being set-up at the Institut Pasteur de Dakar and started in early February following the agreement signed between the Institut Pasteur and AUF (Agence universitaire de la francophonie) on 31 January 2019, in collaboration with the Yale School of Public Health. Entitled « Malaria Experimental Genetic Approaches and Vaccines », it will be led by...
Article | 2019.08.06
Clinical Research in Vaccinology and Immunotherapy at Institut Pasteur includes clinical studies with the advanced vaccine candidates developed by Institut Pasteur (described as part of the Innovation – Vaccine candidates, immune-monitoring of Institut Pasteur sponsored clinical trials as well as in collaboration with partners, and cohort and surveillance studies to uncover the disease-specific...